Treatment of Athlete's Foot (Tinea Pedis)
For uncomplicated athlete's foot, apply topical terbinafine 1% cream twice daily for 1 week if infection is between the toes, or twice daily for 2 weeks if on the bottom or sides of the foot. 1
First-Line Topical Treatment
Terbinafine 1% cream is the preferred topical agent, applied twice daily (morning and night) with duration based on location 1:
Before applying medication, wash affected skin with soap and water and dry completely 1
Wear well-fitting, ventilated shoes and change shoes and socks at least once daily 1
Oral Therapy for Extensive or Refractory Cases
When topical therapy fails or infection is extensive, escalate to systemic treatment:
Oral itraconazole is the recommended first-line systemic agent, using pulse dosing of 200-400 mg per day for 1 week per month 3
Alternative continuous dosing: itraconazole 100 mg daily for 2 weeks for extensive tinea pedis 3
Take itraconazole with food and acidic pH for optimal absorption 3
Fluconazole 150 mg once weekly as pulse therapy is less effective than terbinafine or itraconazole but can serve as an alternative option 3
Monitor liver function tests at baseline and during prolonged therapy, especially with itraconazole 3
Critical Adjunctive Measures to Prevent Recurrence
Treatment of the feet alone without addressing these factors leads to high recurrence rates:
Apply foot powder after bathing, which reduces recurrence from 8.5% to 2.1% 3
Change socks daily and clean athletic footwear periodically to prevent reinfection 3
Examine and treat concomitant onychomycosis (nail infection), as it serves as a reservoir for reinfection 3
Check for dermatophyte infection at other body sites (present in 25% of cases) and treat all infected family members simultaneously 3
Management of Treatment Failure
Before assuming true treatment failure:
Obtain fungal cultures to verify treatment failure; consider discontinuing antifungals for a few days to optimize specimen collection 3
Poor compliance, inadequate drug penetration, bacterial superinfection, or reinfection from nails/footwear are more common causes of apparent treatment failure than drug resistance 3
Consider culture at end of treatment to confirm mycological clearance 3
Common Pitfalls to Avoid
Do not treat feet in isolation—failure to address nail involvement or other body sites leads to recurrence 3
Do not assume treatment failure is due to drug resistance alone without investigating compliance and reinfection sources 3
Do not neglect footwear hygiene and daily sock changes, as these are essential for preventing reinfection 3, 1